← Back to All Stocks
CASI Pharmaceuticals, Inc. (CASI) Analysis
Generated on: 2025-08-20 18:37:33 UTC
All stock prices are delayed.
Use of this site does not constitute financial advice.
⚠️ VERY LOW FLOAT STOCK - 5,971,964 shares
Analysis Values
Current Price
$2.45
Predicted Price
$1.95
Expected Return
-16.39%
Confidence Score
0.80
RSI (14)
72.50 (sell)
MACD
0.21
Volume
164,949
Float Shares
5,971,964
Reddit Posts
0
News Items
1
SEC Filings
0
Data Points
251
CASI
CASI Pharmaceuticals, Inc.
-16.39%
Price: $2.45
Confidence: 0.80
News
Low Float
Last updated: 2025-08-20 18:37:32
Technical Analysis
RSI:
72.50 (sell)
MACD: 0.21
Risk Analysis
Volatility
105.58%
Max Drawdown
-84.37%
Beta
1.0
Risk Score
96.0
Social Sentiment
0
Social Sentiment Score (0-100)
Recent News
VYNE Therapeutics Inc. (VYNE) Reports Q2 Loss, Lags Revenue Estimates
Zacks - 2025-08-14 13:15
VYNE Therapeutics (VYNE) delivered earnings and revenue surprises of +43.48% and -31.00%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Reddit Discussions
No recent Reddit discussions found.
Recent SEC Filings
No recent SEC filings found.
